These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 23789590)

  • 1. Vaginal microbiota and its role in HIV transmission and infection.
    Petrova MI; van den Broek M; Balzarini J; Vanderleyden J; Lebeer S
    FEMS Microbiol Rev; 2013 Sep; 37(5):762-92. PubMed ID: 23789590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the vaginal microbiota with probiotics as a means to counteract infections.
    Reid G; Dols J; Miller W
    Curr Opin Clin Nutr Metab Care; 2009 Nov; 12(6):583-7. PubMed ID: 19741517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner.
    Doerflinger SY; Throop AL; Herbst-Kralovetz MM
    J Infect Dis; 2014 Jun; 209(12):1989-99. PubMed ID: 24403560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of infection and transmission of HIV-1 and lack of significant impact on the vaginal commensal lactobacilli by carbohydrate-binding agents.
    Petrova MI; Mathys L; Lebeer S; Noppen S; Van Damme EJ; Tanaka H; Igarashi Y; Vaneechoutte M; Vanderleyden J; Balzarini J
    J Antimicrob Chemother; 2013 Sep; 68(9):2026-37. PubMed ID: 23640125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between sex hormones, the vaginal microbiome and immunity in HIV-1 susceptibility in women.
    Wessels JM; Felker AM; Dupont HA; Kaushic C
    Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30154116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The barrier to HIV transmission provided by genital tract Lactobacillus colonization.
    Mirmonsef P; Spear GT
    Am J Reprod Immunol; 2014 Jun; 71(6):531-6. PubMed ID: 24661438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of vaginal microbiota in sub-Saharan Africa and its effects on HIV transmission and prevention.
    Bayigga L; Kateete DP; Anderson DJ; Sekikubo M; Nakanjako D
    Am J Obstet Gynecol; 2019 Feb; 220(2):155-166. PubMed ID: 30321529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells.
    Zárate G; Nader-Macias ME
    Lett Appl Microbiol; 2006 Aug; 43(2):174-80. PubMed ID: 16869901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota.
    Delgado-Diaz DJ; Tyssen D; Hayward JA; Gugasyan R; Hearps AC; Tachedjian G
    Front Cell Infect Microbiol; 2019; 9():446. PubMed ID: 31998660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of sex hormones and the vaginal microbiome in susceptibility and mucosal immunity to HIV-1 in the female genital tract.
    Vitali D; Wessels JM; Kaushic C
    AIDS Res Ther; 2017 Sep; 14(1):39. PubMed ID: 28893284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gynecologic health and disease in relation to the microbiome of the female reproductive tract.
    Green KA; Zarek SM; Catherino WH
    Fertil Steril; 2015 Dec; 104(6):1351-7. PubMed ID: 26597627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urogenital pathogen inhibition and compatibility between vaginal Lactobacillus strains to be considered as probiotic candidates.
    Juárez Tomás MS; Saralegui Duhart CI; De Gregorio PR; Vera Pingitore E; Nader-Macías ME
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):399-406. PubMed ID: 21862199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis.
    Sha BE; Zariffard MR; Wang QJ; Chen HY; Bremer J; Cohen MH; Spear GT
    J Infect Dis; 2005 Jan; 191(1):25-32. PubMed ID: 15592999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defence factors of vaginal lactobacilli.
    Kovachev S
    Crit Rev Microbiol; 2018 Feb; 44(1):31-39. PubMed ID: 28418713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vaginal microbiota and susceptibility to HIV.
    Buve A; Jespers V; Crucitti T; Fichorova RN
    AIDS; 2014 Oct; 28(16):2333-44. PubMed ID: 25389548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lactobacilli administration in the vaginal tract of mice: evaluation of side effects and local immune response by local administration of selected strains.
    Vintiñi E; Ocaña V; Elena Nader-Macías M
    Methods Mol Biol; 2004; 268():401-10. PubMed ID: 15156050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lower genital tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH).
    Nikolaitchouk N; Andersch B; Falsen E; Strömbeck L; Mattsby-Baltzer I
    APMIS; 2008 Apr; 116(4):263-77. PubMed ID: 18397461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal microbiota and sexually transmitted infections that may influence transmission of cell-associated HIV.
    Cone RA
    J Infect Dis; 2014 Dec; 210 Suppl 3(Suppl 3):S616-21. PubMed ID: 25414415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genital econiche: focus on microbiota and bacterial vaginosis.
    Danielsson D; Teigen PK; Moi H
    Ann N Y Acad Sci; 2011 Aug; 1230():48-58. PubMed ID: 21824165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Lactobacilli and Lactoferrin in the Mucosal Cervicovaginal Defense.
    Valenti P; Rosa L; Capobianco D; Lepanto MS; Schiavi E; Cutone A; Paesano R; Mastromarino P
    Front Immunol; 2018; 9():376. PubMed ID: 29545798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.